11/13
04:15 pm
nbtx
Voting Rights and Shares Capital of the Company
Medium
Report
Voting Rights and Shares Capital of the Company
11/12
02:30 am
nbtx
NANOBIOTIX Provides Third Quarter 2024 Update and Progress on Nanotherapeutics Platforms
Low
Report
NANOBIOTIX Provides Third Quarter 2024 Update and Progress on Nanotherapeutics Platforms
10/31
03:30 am
nbtx
NANOBIOTIX to Participate in Multiple Investor Conferences in November
Medium
Report
NANOBIOTIX to Participate in Multiple Investor Conferences in November
10/11
04:15 pm
nbtx
Voting Rights and Shares Capital of the Company
Low
Report
Voting Rights and Shares Capital of the Company
9/18
04:15 pm
nbtx
NANOBIOTIX Provides Business Update and Reports Half Year 2024 Financial Results
Medium
Report
NANOBIOTIX Provides Business Update and Reports Half Year 2024 Financial Results
9/4
04:15 pm
nbtx
NANOBIOTIX Announces Two Key Supervisory Board Additions Intended to Further Equip the Company for Sustainable Long-Term Growth
Low
Report
NANOBIOTIX Announces Two Key Supervisory Board Additions Intended to Further Equip the Company for Sustainable Long-Term Growth
9/3
04:15 pm
nbtx
Nanobiotix to Present at H.C. Wainwright 26th Annual Global Investment Conference
Medium
Report
Nanobiotix to Present at H.C. Wainwright 26th Annual Global Investment Conference
8/29
03:22 am
nbtx
How nanotechnology is subtly shaping sectors [Yahoo! Finance]
Medium
Report
How nanotechnology is subtly shaping sectors [Yahoo! Finance]
8/28
08:06 am
nbtx
Nanobiotix S.A. (NASDAQ: NBTX) is now covered by analysts at Guggenheim. They set a "buy" rating and a $12.00 price target on the stock.
Low
Report
Nanobiotix S.A. (NASDAQ: NBTX) is now covered by analysts at Guggenheim. They set a "buy" rating and a $12.00 price target on the stock.